The anti-HIV-1 effect of scutellarin

Biochemical and Biophysical Research Communications

Volumn 334, Issue 3, 2005, Pages 812-816

  Zhang, Gao Hong ^a,d   Wang, Qian ^a,d   Chen, Ji Jun ^b   Zhang, Xue Mei ^b   Tam, Siu Cheung ^c   Zheng, Yong Tang ^a  

^a KUNMING INSTITUTE OF ZOOLOGY   (China)

^b KUNMING INSTITUTE OF BOTANY   (China)

^c CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^d UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

Author keywords

Anti HIV agent; HIV entry; HIV 1; Reverse transcriptase; Scutellarin

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; SCUTELLAREIN;

ARTICLE; CELL FUSION; CELL LINE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; DRUG POTENCY; DRUG PURIFICATION; EXPERIMENTAL INFECTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; VIRUS ADSORPTION; VIRUS ISOLATION; VIRUS PARTICLE; VIRUS RECOMBINANT; VIRUS REPLICATION; VIRUS STRAIN; VIRUS TRANSMISSION;

ANTI-HIV AGENTS; APIGENIN; CELL LINE; GLUCURONIC ACIDS; HIV-1 REVERSE TRANSCRIPTASE; HUMANS; VIRUS REPLICATION;

ERIGERON BREVISCAPUS; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 22744459200     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2005.06.166     Document Type: Article

References (31)

1. R.W. Buckheit Jr., C. Lackman-Smith, M.J. Snow, S.M. Halliday, E.L. White, L.J. Ross, V.K. Agrawal, and A.D. Broom PMTI, a broadly active unusual single-stranded polyribonucleotide, inhibits human immunodeficiency virus replication by multiple mechanisms Antivir. Chem. Chemother. 10 1999 23 32
2. D.J. Clanton, R.A. Moran, J.B. McMahon, O.S. Weislow, R.W. Buckheit Jr., M.G. Hollingshead, V. Ciminale, B.K. Felber, G.N. Pavlakis, and J.P. Bader Sulfonic acid dyes: inhibition of the human immunodeficiency virus and mechanism of action J. Acquir. Immune. Defic. Syndr. 5 1992 771 781
3. A. Steinkasserer, R. Harrison, A. Billich, F. Hammerschmid, G. Werner, B. Wolff, P. Peichl, G. Palfi, W. Schnitzel, and E. Mlynar Mode of action of SDZ NIM 811, a non-immunosuppressive cyclosporin A analog with activity against human immunodeficiency virus type 1 (HIV-1): interference with early and late events in HIV-1 replication J. Virol. 69 1995 814 824
4. M. Witvrouw, C. Pannecouque, V. Fikkert, A. Hantson, B. Van Remoortel, M. Hezareh, E. De Clercq, and S.J. Brown Potent and selective inhibition of HIV and SIV by prostratin interacting with viral entry Antivir. Chem. Chemother. 14 2003 321 328
5. K. Ono, and H. Nakane Mechanisms of inhibition of various cellular DNA and RNA polymerases by several flavonoids J. Biochem. (Tokyo) 108 1990 609 613
6. K. Ono, H. Nakane, M. Fukushima, J.C. Chermann, and F. Barre-Sinoussi Differential inhibitory effects of various flavonoids on the activities of reverse transcriptase and cellular DNA and RNA polymerases Eur. J. Biochem. 190 1990 469 476
7. D.Y. Liu, J.T. Ye, W.H. Yang, J. Yan, C.H. Zeng, and S. Zeng Ampelopsin, a small molecule inhibitor of HIV-1 infection targeting HIV entry Biomed. Environ. Sci. 17 2004 153 164
8. H. Liu, X.L. Yang, Y. Wang, X.Q. Tang, D.Y. Jiang, and H.B. Xu Protective effects of scutellarin on superoxide-induced oxidative stress in rat cortical synaptosomes Acta Pharmacol. Sin. 24 2003 1113 1117
9. X.F. Yang, W. He, W.H. Lu, and F.D. Zeng Effects of scutellarin on liver function after brain ischemia/reperfusion in rats Acta. Pharmacol. Sin. 24 2003 1118 1124
10. X.H. Jiang, S.H. Li, K. Lan, J.Y. Yang, and J. Zhou Study on the pharmacokinetics of scutellarin in dogs Acta Pharmacol. Sin. 38 2003 371 373
11. Y.M. Liu, A.H. Lin, H. Chen, and F.D. Zeng Study on pharmacokinetics of scutellarin in rabbits Acta Pharmacol. Sin. 38 2003 775 778
12. A.M. Vandamme, M. Witvrou, C. Pannecouque, J. Balzarini, K. Van Laethem, J.C. Schmit, J. Desmyter, and E. De Clercq Evaluating clinical isolates for their phenotypic and genotypic resistance against anti-HIV drugs D. Kinchington R.F. Schinazi Antiviral Methods and protocols 2000 Humanae Press Clifton 223 231
13. Y.T. Zheng, W.F. Zhang, K.L. Ben, and J.H. Wang In vitro immunotoxicity and cytotoxicity of trichosanthin against human normal immunocytes and leukemia-lymphoma cells Immunopharmacol. Immunotoxicol. 17 1995 69 79
14. Y.T. Zheng, K.L. Ben, and S.W. Jin Anti-HIV-1 activity of trichobitacin, a novel ribosome-inactivating protein Acta Pharmacol. Sin. 21 2000 179 182
15. J.H. Wang, H.L. Nie, S.C. Tam, H. Huang, and Y.T. Zheng Independency of anti-HIV activity from ribosome inactivating activity of trichosanthin Biochem. Biophys. Res. Commun. 302 2003 89 94
16. Q. Wang, Z.H. Ding, J.K. Liu, and Y.T. Zheng Xanthohumol, a novel anti-HIV-1 agent purified from Hop Humulus lupulus Antiviral Res. 64 2004 189 194
17. C. Callebaut, S. Nisole, J.P. Briand, B. Krust, and A.G. Hovanessian Inhibition of HIV infection by the cytokine midkine Virology 281 2001 248 264
18. A. Valenzuela, J. Blanco, B. Krust, R. Franco, and A.G. Hovanessian Neutralizing antibodies against the V3 loop of human immunodeficiency virus type 1 gp120 block the CD4-dependent and -independent binding of virus to cells J. Virol. 71 1997 8289 8298
19. E. De Clercq New developments in anti-HIV chemotherapy Biochim. Biophys. Acta 1587 2002 258 275
20. L.A. Cooley, and S.R. Lewin HIV-1 cell entry and advances in viral entry inhibitor therapy J. Clin. Virol. 26 2003 121 132
21. B.Q. Li, T. Fu, Y. Dongyan, J.A. Mikovits, F.W. Ruscetti, and J.M. Wang Flavonoid baicalin inhibits HIV-1 infection at the level of viral entry Biochem. Biophys. Res. Commun. 276 2000 534 538
22. K. Yamaguchi, M. Honda, H. Ikigai, Y. Hara, and T. Shimamura Inhibitory effects of (-)-epigallocatechin gallate on the life cycle of human immunodeficiency virus type 1 (HIV-1) Antiviral Res. 53 2002 19 34
23. H. Liu, X. Yang, L. Zhou, and H. Xu Study on effects of scutellarin on scavenging reactive oxygen Zhong Yao Cai. 25 2002 491 493
24. H.C. Ahn, S.Y. Lee, J.W. Kim, W.S. Son, C.G. Shin, and B.J. Lee Binding aspects of baicalein to HIV-1 integrase Mol. Cells 12 2001 127 130
25. M.J. Ahn, C.Y. Kim, J.S. Lee, T.G. Kim, S.H. Kim, C.K. Lee, B.B. Lee, C.G. Shin, H. Huh, and J. Kim Inhibition of HIV-1 integrase by galloyl glucoses from Terminalia chebula and flavonol glycoside gallates from Euphorbia pekinensis Planta Med. 68 2002 457 459
26. M. Shimura, Y. Zhou, Y. Asada, T. Yoshikawa, K. Hatake, F. Takaku, and Y. Ishizaka Inhibition of Vpr-induced cell cycle abnormality by quercetin: a novel strategy for searching compounds targeting Vpr Biochem. Biophys. Res. Commun. 261 1999 308 316
27. C.W. Mahoney, A. Azzi, and K.P. Huang Effects of suramin, an anti-human immunodeficiency virus reverse transcriptase agent, on protein kinase C. Differential activation and inhibition of protein kinase C isozymes J. Biol. Chem. 265 1990 5424 5428
28. E.L. White, W.R. Chao, L.J. Ross, D.W. Borhani, P.D. Hobbs, V.U. pender, and M.I. Dawson Michellamine alkaloids inhibit protein kinase C Arch. Biochem. Biophys. 365 1999 25 30
29. L. Gamet-Payrastre, S. Manenti, M.P. Gratacap, J. Tulliez, H. Chap, and B. Payrastre Flavonoids and the inhibition of PKC and PI 3-kinase Gen. Pharmacol. 32 1999 279 286
30. G. Xu, L.P. Zhang, H.F. Shen, and C.Q. Hu Inhibition of protein kinase C by scutellarein and its analogues Acta. Acad. Med. Shanghai. 20 1993 187 191
31. J. Shuai, and W.W. Dong Experimental research of PKC inhibitor, Erigeron breviscapus on the ischemic/reperfusional brain injury Chin. Pharmacol. Bull. 14 1998 75 77